The PI3K/AKT pathway contributes to arenavirus budding

Journal of Virology

Volumn 86, Issue 8, 2012, Pages 4578-4585

  Urata, Shuzo ^a,b   Ngo, Nhi ^a   de la Torre, Juan Carlos ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PRIORITY JOURNAL; PROTEIN TARGETING; RNA REPLICATION; VIROGENESIS; VIRUS ENTRY; VIRUS GENE; VIRUS INHIBITION; VIRUS RELEASE;

ANIMALS; ARENAVIRUS; CELL LINE; CERCOPITHECUS AETHIOPS; CHROMONES; GENE EXPRESSION REGULATION, VIRAL; HUMANS; IMIDAZOLES; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; QUINOLINES; RNA, VIRAL; SIGNAL TRANSDUCTION; SIROLIMUS; VIRUS INTERNALIZATION; VIRUS RELEASE; VIRUS REPLICATION;

ARENAVIRUS; JUNIN VIRUS; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 84861379061     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06604-11     Document Type: Article

References (41)

1. Arita M, Wakita T, Shimizu H. 2009. Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime. J. Gen. Virol. 90:1869-1879.
2. Barnett SF, et al. 2005. Identification and characterization of pleckstrinhomology-domain-dependent and isoenzyme-specific Akt inhibitors. Biochem. J. 385:399-408.
3. Barton LL, Mets MB, Beauchamp CL. 2002. Lymphocytic choriomeningitis virus: emerging fetal teratogen. Am. J. Obstet. Gynecol. 187:1715-1716.
4. Battegay M. 1993. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates. ALTEX 10:6-14.
5. Brognard J, Sierecki E, Gao T, Newton AC. 2007. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol. Cell 25:917-931.
6. Buchmeier MJ, Peters CJ, de la Torre JC. 2007. Arenaviridae: the viruses and their replication, p 1791-1851. In Knipe DM, et al (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
7. Cao W, et al. 1998. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282: 2079-2081.
8. Crouch SP, Kozlowski R, Slater KJ, Fletcher J. 1993. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J. Immunol. Methods 160:81-88.
9. Damonte EB, Coto CE. 2002. Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy. Adv. Virus Res. 58:125-155.
10. Dunn EF, Connor JH. 2011. Dominant inhibition of Akt/protein kinase B signaling by the matrix protein of a negative-strand RNA virus. J. Virol. 85:422-431.
11. Dunn EF, Fearns R, Connor JH. 2009. Akt inhibitor Akt-IV blocks virus replication through an Akt-independent mechanism. J. Virol. 83:11665-11672.
12. Emonet SF, Garidou L, McGavern DB, de la Torre JC. 2009. Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc. Natl. Acad. Sci. U. S. A. 106:3473-3478.
13. Fischer SA, et al. 2006. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354:2235-2249.
14. Franke TF. 2008. Intracellular signaling by Akt: bound to be specific. Sci. Signal. 1:pe29.
15. Jahrling PB, Peters CJ. 1992. Lymphocytic choriomeningitis virus. A neglected pathogen of man. Arch. Pathol. Lab. Med. 116:486-488.
16. Kau TR, et al. 2003. A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTENdeficient tumor cells. Cancer Cell 4:463-476.
17. Kunz S. 2009. Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction. Virology 387:245-249.
18. Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC. 2000. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J. Virol. 74:3470-3477.
19. Lee KJ, Perez M, Pinschewer DD, de la Torre JC. 2002. Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J. Virol. 76:6393-6397.
20. Linero FN, Scolaro LA. 2009. Participation of the phosphatidylinositol 3-kinase/Akt pathway in Junin virus replication in vitro. Virus Res. 145: 166-170.
21. Liu P, Cheng H, Roberts TM, Zhao JJ. 2009. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 8:627-644.
22. Liu TJ, et al. 2009. NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas. Mol. Cancer Ther. 8:2204-2210.
23. Luyet PP, Falguieres T, Pons V, Pattnaik AK, Gruenberg J. 2008. The ESCRT-I subunit TSG101 controls endosome-to-cytosol release of viral RNA. Traffic 9:2279-2290.
24. Mets MB, Barton LL, Khan AS, Ksiazek TG. 2000. Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis. Am. J. Ophthalmol. 130:209-215.
25. Moreno H, et al. 2011. Ribavirin can be mutagenic for arenaviruses. J. Virol. 85:7246-7255.
26. Parker WB. 2005. Metabolism and antiviral activity of ribavirin. Virus Res. 107:165-171.
27. Pasqual G, Rojek JM, Masin M, Chatton JY, Kunz S. 2011. Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog. 7:e1002232.
28. Perez M, Craven RC, de la Torre JC. 2003. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc. Natl. Acad. Sci. U. S. A. 100:12978-12983.
29. Perez M, de la Torre JC. 2003. Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 77:1184-1194.
30. Peters CJ. 2006. Lymphocytic choriomeningitis virus-an old enemy up to new tricks. N. Engl. J. Med. 354:2208-2211.
31. Pinschewer DD, Perez M, de la Torre JC. 2005. Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation. J. Virol. 79:4519-4526.
32. Pinschewer DD, Perez M, de la Torre JC. 2003. Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J. Virol. 77:3882-3887.
33. Radoshitzky SR, et al. 2007. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96.
34. Saeed MF, Kolokoltsov AA, Freiberg AN, Holbrook MR, Davey RA. 2008. Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog. 4:e1000141.
35. Schu PV, et al. 1993. Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science 260:88-91.
36. Serra V, et al. 2008. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations. Cancer Res. 68:8022-8030.
37. Strecker T, et al. 2003. Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles. J. Virol. 77:10700-10705. (Erratum, 77:12927.)
38. Sun M, et al. 2008. Akt plays a critical role in replication of nonsegmented negative-stranded RNA viruses. J. Virol. 82:105-114.
39. Urata S, Noda T, Kawaoka Y, Yokosawa H, Yasuda J. 2006. Cellular factors required for Lassa virus budding. J. Virol. 80:4191-4195.
40. Urata S, Yasuda J, de la Torre JC. 2009. The Z protein of the New World arenavirus Tacaribe virus has bona fide budding activity that does not depend on known late domain motifs. J. Virol. 83:12651-12655.
41. Urata S, et al. 2011. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease. J. Virol. 85:795-803.